RHYTHMIA HDx Mapping System

RHYTHMIA HDx Mapping System is an FDA 510(k)-cleared medical device (K162793) manufactured by Boston Scientific Corporation. This device is classified under the Cardiovascular specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on March 9, 2017. Regulation: 8.